ScholarIQanswers from OpenAlex & ORCID
Ritsuko Komaki
ResearcherPublications, citations & collaboration network
Ritsuko Komaki is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ritsuko Komaki have?
ScholarIQindexed works
Ritsuko Komaki has 283 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ritsuko Komaki have?
ScholarIQcitation count
Ritsuko Komaki has 19,671 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ritsuko Komaki?
ScholarIQh-index
Ritsuko Komaki has an h-index of 68 in OpenAlex.
What is the i10-index of Ritsuko Komaki?
ScholarIQi10-index
Ritsuko Komaki has an i10-index of 141 in OpenAlex.
What is the ORCID of Ritsuko Komaki?
ScholarIQorcid
The ORCID for Ritsuko Komaki is on the source record.
What is the OpenAlex record for Ritsuko Komaki?
ScholarIQopenalex
The OpenAlex for Ritsuko Komaki is on the source record.
What are the most-cited papers on Ritsuko Komaki?
ScholarIQmost cited works
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki, Gregory A. Masters, George Blumenschein, Steven E. Schild, Jeffrey A. Bogart, Chen Hu, Kenneth Forster, Anthony M. Magliocco, Vivek S. Kavadi, Yolanda I. Garces, Samir Narayan, Puneeth Iyengar, Clifford G. Robinson, Raymond B. Wynn, Christopher D. Koprowski, Joanne Meng, Jonathan J. Beitler, Rakesh Gaur, Walter J. Curran, Hak Choy
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
Daniel R. Gomez, George R. Blumenschein, J Jack Lee, Mike Hernández, Rong Ye, D. Ross Camidge, Robert C. Doebele, Ferdinandos Skoulidis, Laurie E. Gaspar, Don L. Gibbons, José A. Karam, Brian D. Kavanagh, Chad Tang, Ritsuko Komaki, Alexander V. Louie, David A. Palma, Anne S. Tsao, Boris Sepesi, William N. William, Jianjun Zhang, Qiuling Shi, Xin Shelley Wang, Stephen G. Swisher, John V. Heymach
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer
Jeffrey D. Bradley, Chen Hu, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein, Steven E. Schild, Jeffrey A. Bogart, Kenneth Forster, Anthony M. Magliocco, Vivek S. Kavadi, Samir Narayan, Puneeth Iyengar, Clifford G. Robinson, Raymond B. Wynn, Christopher D. Koprowski, Michael R. Olson, Joanne Meng, Rebecca Paulus, Walter J. Curran, Hak Choy